measurement
In a clinical trial analyzed by Lamas et al. (2013), the overall reduction in end points including myocardial infarction, cerebrovascular accident, and death was approximately 18% in the general population, while the subset of diabetic patients experienced an overall risk reduction of 45%.

Authors

Sources

Referenced by nodes (2)